CD8
+ T cells obtained from a healthy HLA-A*02-01 donor were transduced using a lentiviral vector encoding a MART1-specific TCR, which was a generous gift donated by Richard Koya (20 (
link)). Primary PC cells isolated as previously described (16 (
link),17 (
link)), were evaluated for HLA A2 expression using flow cytometry with a commercially validated antibody (Biolegend) and a representative HLA A2-positive line was chosen. 2.5×10
4 PC cells were seeded in 96 well plates and allowed to adhere overnight in growth medium. Transgenic T cells were added at the indicated effector:target T cell ratio in the presence and absence of the recombinant
MART1 peptide (12.5 µM, ProImmune Ltd., Oxford, United Kingdom). Images were collected on an
EVOS FL digital inverted microscope (Life Technologies, Carlsbad, CA) and processed with ImageJ (NIH). The
CellTracker™ Blue (CMAC) dye was used to label T cells and co-cultures were performed in the presence of SYTOX® Green for live cell imaging (Thermo Fisher Scientific).
Delitto D., Delitto A.E., DiVita B.B., Pham K., Han S., Hartlage E.R., Newby B.N., Gerber M.H., Behrns K.E., Moldawer L.L., Thomas R.M., George TJ J.r., Brusko T.M., Mathews C.E., Liu C., Trevino J.G., Hughes S.J, & Wallet S.M. (2016). Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response To Promote a Tumor-Tolerant Immune Microenvironment. Cancer research, 77(3), 672-683.